Shots: The US FDA has granted approval to Myxredlin as the first ready-to-use insulin for IV infusion in the hospital with an extended shelf-life of 30 days @25◦C or 24 mos. if refrigerated @2-8◦C Myxredlin utilizes Baxter’s Galaxy container technology which is a non-PVC and non-DEHP system enabling premixed medicines to have a longer shelf […]Read More
